Anti-Fibrotic Effects of Astragaloside IV in Systemic Sclerosis

Anti-Fibrotic Effects of Astragaloside IV in Systemic Sclerosis

Objective: To evaluate the anti-fibrotic effects of Astragaloside IV in systemic sclerosis. Methods: Treated or untreated systemic sclerosis (SSc) and normal fibroblast isolated from corresponding pairs were utilized to detect expression of collagen and fibronectin by western blot, quantitative real...

Full description

Bibliographic Details
Main Authors: Qing Qi, Yueping Mao, Juanjuan Yi, Donghai Li, Ke Zhu, Xushan Cha
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2014-11-01
Series:Cellular Physiology and Biochemistry
Subjects:
Systemic sclerosis (SSc)
Fibrosis
Transforming growth factor β (TGF-β)
Collagen I
Fibronectin
Online Access:http://www.karger.com/Article/FullText/366405

Internet

http://www.karger.com/Article/FullText/366405

Similar Items